Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LPA”

138 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 138 results

Testing effectiveness (Phase 2)Study completedNCT05565742
What this trial is testing

LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

Who this might be right for
Lipoprotein Disorder
Eli Lilly and Company 320
Testing effectiveness (Phase 2)Study completedNCT04270760
What this trial is testing

Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study

Who this might be right for
Cardiovascular Disease
Amgen 281
Large-scale testing (Phase 3)Study completedNCT01757184
What this trial is testing

Acid Lipase Replacement Investigating Safety and Efficacy (ARISE) in Participants With Lysosomal Acid Lipase Deficiency

Who this might be right for
Lysosomal Acid Lipase Deficiency
Alexion Pharmaceuticals, Inc. 66
Not applicableStudy completedNCT03887520
What this trial is testing

Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)

Who this might be right for
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals 49,001
Large-scale testing (Phase 3)Active Not RecruitingNCT04023552
What this trial is testing

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

Who this might be right for
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals 8,323
Large-scale testing (Phase 3)Active Not RecruitingNCT05900141
What this trial is testing

An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Who this might be right for
Hyperlipoproteinemia (a)
Novartis Pharmaceuticals 41
Not applicableStudy completedNCT00257907
What this trial is testing

Immune Response to Mycobacterium Tuberculosis Infection

Who this might be right for
Latent Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 157
Not applicableUnknownNCT05323227
What this trial is testing

Lp(a) With CCTA Assessed Parameters and Clinical Outcomes

Who this might be right for
Coronary Artery Disease
Shanghai Zhongshan Hospital 378
Not applicableUnknownNCT05330819
What this trial is testing

Thrombogenicity of Lipoprotein A: Laboratory Study Defining the Prothrombotic Effects of Lipoprotein A

Who this might be right for
Cardiovascular Disease and Lipid DisordersCardiac Disease
South Tees Hospitals NHS Foundation Trust 20
Large-scale testing (Phase 3)Looking for participantsNCT06597006
What this trial is testing

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia - Homozygous
Novartis Pharmaceuticals 9
Not applicableStudy completedNCT01690312
What this trial is testing

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Who this might be right for
Cardiovascular Disease
Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 36
Large-scale testing (Phase 3)UnknownNCT00633698
What this trial is testing

Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study)

Who this might be right for
Elevated Lipoprotein(a) Levels
Charite University, Berlin, Germany 150
Post-approval studies (Phase 4)UnknownNCT02501850
What this trial is testing

The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)

Who this might be right for
Diabetes Mellitus Type 2
Hospital Universitari Vall d'Hebron Research Institute 40
Large-scale testing (Phase 3)Enrolling By InvitationNCT06406140
What this trial is testing

Study the Effect of Niacin on Lipoprotein (a) Concentration and Hyperphosphatemia in Hemodialysis Patients

Who this might be right for
End-stage Renal Disease
Al-Azhar University 50
Not applicableUnknownNCT06297239
What this trial is testing

Argentine Registry of Lp(a)

Who this might be right for
Lp(A)HypercholesterolemiaCardiovascular Diseases+2 more
School of Medicine. National University of Cuyo 1,000
Early research (Phase 1)Not Yet RecruitingNCT07551505
What this trial is testing

Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a)

Who this might be right for
Dyslipidemias
Bisirna Therapeutics (Suzhou) Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT02112994
What this trial is testing

Safety and Efficacy Study of Sebelipase Alfa in Participants With Lysosomal Acid Lipase Deficiency

Who this might be right for
Lysosomal Acid Lipase Deficiency
Alexion Pharmaceuticals, Inc. 31
Not applicableLooking for participantsNCT07324902
What this trial is testing

The Effect of Lipoprotein (a) on Arterial Stiffness, Endothelial Function and Myocardial Deformation

Who this might be right for
Lipoprotein DisorderArterial StiffnessEndothelial Dysfunction
University of Athens 300
Not applicableUnknownNCT05090878
What this trial is testing

Atherogenic Lipoproteins in Ischemic Stroke

Who this might be right for
Ischemic Stroke
University Hospital, Basel, Switzerland 500
Not applicableLooking for participantsNCT06995183
What this trial is testing

Heart CT Imaging to Detect Early Coronary Artery Disease in First-Degree Relatives With High or Low Lipoprotein(a) Identified Through Family Screening

Who this might be right for
Lipoprotein(a)
E.S.stroes 150
Load More Results